$PDII #Stocks #StockMarket #InterpaceBiosciences reported Q4 EPS on https://t.co/savSNTKlN1: Weak demand caused increase in losses for the Q4, company's loss per share grew to $-0.29 from $-0.14 where Sales fell by -30.156 % to $4.074 MM from $5.833 MM a… https://t.co/qE65dnyX2q